Primary Prevention of Ischemic Stroke with Aspirin or Statins for Patients with Fibromuscular Dysplasia: A Retrospective Case-control Study (P10-5.001) | Synapse
June 13, 2026
Primary Prevention of Ischemic Stroke with Aspirin or Statins for Patients with Fibromuscular Dysplasia: A Retrospective Case-control Study (P10-5.001)
Key Points
This study evaluates the effectiveness of aspirin and statins in preventing ischemic stroke in patients with fibromuscular dysplasia.
Retrospective case-control design
Evaluation of aspirin and statin use among patients with fibromuscular dysplasia
Aspirin and statins show varying levels of efficacy in preventing ischemic stroke in this population
Specific event rates and statistical data not provided in abstract
Abstract
This study aims to assess the efficacy of aspirin and statin use in the primary prevention of stroke for patients with fibromuscular dysplasia (FMD).